• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FPRX

    Five Prime Therapeutics, Inc.

    Subscribe to $FPRX
    $FPRX
    Major Pharmaceuticals
    Health Care

    IPO Year: 2013

    Exchange: NASDAQ

    Recent Analyst Ratings for Five Prime Therapeutics, Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Five Prime Therapeutics, Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Sarena Francis Willard received a gift of 2,385 units of Common Stock, was granted 66,000 units of Common Stock, disposed of $6,530,414 worth of Common Stock back to the company (171,853 units at $38.00) and gifted 20,459 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy withholding obligation

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 8:04:26 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: Smith David V was granted 66,000 units of Common Stock and disposed of $5,279,986 worth of Common Stock back to the company (138,947 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:57:02 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: Collins Helen Louise disposed of $5,150,786 worth of Common Stock back to the company (135,547 units at $38.00) , gifted 8,085 units of Common Stock and was granted 66,000 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy tax liability

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:53:58 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: White David disposed of $1,270,074 worth of Common Stock back to the company (33,423 units at $38.00) , decreasing direct ownership by 100% to 0 units (tax withholding)

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:49:04 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: RINGO WILLIAM R gifted 10,000 units of Common Stock, decreasing direct ownership by 100% to 0 units

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:46:08 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: BERGER FRANKLIN M disposed of $190,000 worth of Common Stock back to the company (5,000 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:42:33 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Dhingra Kapil

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:39:43 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Jensen Peder

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:35:28 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Nicholson Garry A

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:32:22 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4 filed by SCHAFER CAROL

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:28:40 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care